Treatment
Treatment clinical trials
We’re tracking 8,313 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT06280378RecruitingPhase 1/Phase 2
KL003 stem cell treatment for beta-thalassemia
This trial tests a new treatment called KL003 for people with beta-thalassemia who need regular blood transfusions. The treatment uses your own stem cells (collected from your blood) to try to reduce or stop the need for transfusions.
Shanghai, Shanghai MunicipalityAges 3–35 - NCT06324071Recruiting
Study of TetraSOD for male infertility
This trial tests if a supplement called TetraSOD can improve sperm quality in men with infertility of unknown cause. It may help if you and your partner have been trying for at least a year without success.
BarcelonaAges 18–45 - NCT06736314Recruiting
Removable clip treatment for stomach varices bleeding
This trial tests a removable titanium clip to stop bleeding from enlarged veins in the stomach caused by cirrhosis. It may be an option for patients who are stable enough for this procedure.
Nanjing, JiangsuAges 18–75 - NCT06736301Recruiting
Stent fixation for benign duodenal strictures
This trial tests a method to keep a metal stent in place using a plastic stent for people with non-cancerous narrowing in the first part of the small intestine. It may help if you have symptoms like nausea or vomiting and other treatments have not worked.
Nanjing, JiangsuAges Up to 75 years - NCT06773312RecruitingPhase 1
Study of BC001 plus Sintilimab and XELOX for advanced stomach cancer
This trial tests a combination of three drugs (BC001, Sintilimab, and XELOX chemotherapy) for people with advanced or metastatic HER-2 negative stomach cancer or cancer where the stomach meets the esophagus. The goal is to see if this combination works better than standard treatments.
Beijing, Beijing MunicipalityAges 18–75 - NCT06866223Recruiting
Language therapy study for bilingual children ages 4–6
This study looks at how to best support bilingual children (ages 4–6) who have trouble with advanced sentences. It will test whether therapy in English, Spanish, or both helps them learn grammar more effectively.
Houston, TexasAges 4–6 - NCT05876598Recruiting
Predict bloodstream infection risk using a computer model
This study builds and tests a computer (machine-learning) model to predict bloodstream infections based on what happens in the first days of care. It may help doctors start the right antibiotic faster for patients who truly have an infection.
RomeAges 18 years+ - NCT06863350Recruiting
Closing a heart hole to treat drug-resistant epilepsy
This trial tests if closing a small hole in the heart (called a PFO) can reduce seizures in people whose epilepsy isn't controlled by medication. It might offer a new treatment option for those who have both drug-resistant epilepsy and this heart condition.
Chengdu, SichuanAges 18–60 - NCT06845657Recruiting
Hip strengthening exercises for knee arthritis
This study tests if strengthening the hip muscles can reduce knee pain and improve function in people with knee osteoarthritis. It may help you if you have had knee pain for at least 3 months and are between 40 and 60 years old.
Islamabad, Punjab ProvinceAges 40–60 - NCT07320118Recruiting
Knee cartilage repair and osteoarthritis prevention study
This study looks at whether fixing knee cartilage damage can prevent arthritis later. It compares different treatments to see if they help avoid long-term joint problems.
OswestryAges Any age - NCT07316543Recruiting
Cognitive rehab for veterans with PNES
This study tests a cognitive rehabilitation program designed to help veterans with psychogenic non-epileptic seizures (PNES) who are having trouble with thinking and memory. The program is done remotely from home using a computer and internet.
Providence, Rhode IslandAges 18 years+ - NCT07319871RecruitingPhase 1
Study of two drugs for prostate cancer
This trial tests a new combination of two drugs, pasritamig and JNJ-86974680, for men with a certain type of advanced prostate cancer that has spread to bone or lymph nodes but not to organs like the lungs or liver. It aims to see if this combination is safe and effective.
Sarasota, FloridaAges 18 years+ - NCT07324707RecruitingPhase 2
Asthma study testing PA9159 inhaled spray
This trial tests an inhaled asthma medication, PA9159, in adults with stable or mild-to-moderate asthma. It aims to see if the drug improves lung function and is safe. You may qualify if you have asthma with some airflow limitation and have not had recent severe flare-ups.
Nanchang, JiangxiAges 18–75 - NCT07323953Recruiting
AmblyoFix study for children with lazy eye
This trial tests a new treatment called AmblyoFix for children aged 7 to 12 with lazy eye (amblyopia) in one eye. The study aims to see if it helps improve vision better than standard care.
CairoAges 7–12 - NCT07321873RecruitingPhase 2
Study of JNJ-88545223 for Active Psoriatic Arthritis
This study tests an experimental drug called JNJ-88545223 to see if it can reduce joint pain, swelling, and skin plaques in people with active psoriatic arthritis. It may help if you have both joint symptoms and psoriasis.
Searcy, ArkansasAges 18 years+ - NCT07322211Recruiting
Testing a new daily disposable contact lens
This trial tests a new daily disposable silicone hydrogel contact lens for people with moderate nearsightedness. It will check if the lens is safe, comfortable, and gives good vision.
Kaohsiung CityAges 3 weeks+ - NCT06870942RecruitingPhase 2
Radiation therapy for liver cancer that progresses after first immunotherapy
This trial tests whether adding targeted radiation to liver cancer patients who have limited progression after initial immunotherapy can help control the disease. It is for people with hepatocellular carcinoma (HCC) whose cancer has started to grow in just a few spots after their first PD-1 treatment.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT04934462Recruiting
Non-surgical or arthroscopic treatment for hip microinstability
This study looks at treatment options that may help people with “hip microinstability,” where the hip can feel unstable or not sit perfectly. Researchers will compare non-surgical care and a minimally invasive surgery option to see what works best and why it helps.
GothenburgAges 18 years+ - NCT07319416Recruiting
Ultrasound study for PRRT response in GEP-NET
This trial tests if a special ultrasound can help doctors see how well treatment is working for a type of slow-growing gut or pancreas cancer (GEP-NET). It may help guide your care if you are starting a therapy called PRRT (peptide receptor radionuclide therapy).
Rome, RomeAges 18 years+ - NCT07321652RecruitingPhase 3
Sonrotoclax plus zanubrutinib for untreated CLL or SLL
This trial tests whether adding a new drug, sonrotoclax, to the standard treatment zanubrutinib works better for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who haven't had treatment before. It's for patients aged 65 and older who need therapy due to symptoms or blood cell issues.
Birmingham, AlabamaAges 65 years+ - NCT07317167Enrolling by invitation
Water safety plan study in Ghana
This trial is testing a water safety plan to improve drinking water quality in Ghana. It may help people who get their water from certain private water suppliers.
AccraAges 18 years+ - NCT07323927RecruitingEarly Phase 1
Testing galcanezumab for Alzheimer's disease
This trial tests whether galcanezumab, an antibody injection, can help people with mild-to-moderate Alzheimer's disease. It is for patients who have a confirmed Alzheimer's diagnosis and a caregiver who can support them.
BeijingAges 50–90 - NCT07317297Recruiting
Shockwave therapy for Peyronie's disease
This trial tests whether sound waves (extracorporeal shockwave therapy) can help men with stable Peyronie's disease reduce curvature and plaque. It's for those whose condition hasn't changed for at least 6 months and who haven't had other treatments.
BakuAges 18–65 - NCT07322341RecruitingPhase 2
Study of SX-682 with atezolizumab for advanced lung cancer
This trial tests a new drug combination (SX-682 plus atezolizumab) for people with advanced non-small cell lung cancer that has grown after standard treatments like immunotherapy and chemotherapy. It aims to see if the combination can help shrink or slow the cancer.
Seattle, WashingtonAges 18 years+
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,313 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.